Home Translating Report News Physicians Diseases Body Sites Lab tests Search
Home Diseases and Health Information

Background

Vibrios are bacteria, probably best known as the causative agent of cholera (Vibrio cholera). However, there are several halophilic or sea-loving Vibrio bacteria that may cause devastating disease in humans.

OUTLINE

Epidemiology  
Disease Associations  
Pathogenesis  
Laboratory/Radiologic/Other Diagnostic Testing  
Gross Appearance and Clinical Variants  
Histopathological Features and Variants  
Special Stains/
Immunohistochemistry/
Electron Microscopy
 
Differential Diagnosis  
Prognosis  
Treatment  
Commonly Used Terms  
Internet Links  

EPIDEMIOLOGY CHARACTERIZATION

Pathogenesis of Vibrio vulnificus.

Linkous DA, Oliver JD.

Department of Biology, University of North Carolina at Charlotte 28223, USA.

FEMS Microbiol Lett 1999 May 15;174(2):207-14 Abstract quote

This review describes the factors which are currently recognized as being central to the virulence of the human pathogen, Vibrio vulnificus.

This estuarine/marine bacterium occurs in high numbers in molluscan shellfish, primarily oysters, and its ingestion in raw oysters results in a ca. 60% mortality in those persons who are susceptible to this bacterium. The organism is also able to produce life-threatening wound infections.

We describe here the nature of both the wound and primary septicemia infections, the virulence factors known or believed to be involved in these infections, possible immunotherapy, and some thoughts on the possibility that not all strains of this pathogen are virulent.

 

DISEASE ASSOCIATION CHARACTERIZATION
HEMODIALYSIS  

Fatal sepsis from Vibrio vulnificus in a hemodialyzed patient.

Stabellini N, Camerani A, Lambertini D, Rossi MR, Bettoli V, Virgili A, Gilli P.

Divisione di Nefrologia, Arcispedale S. Anna, Ferrara, Italia.

Nephron 1998;78(2):221-4 Abstract quote

Vibrio vulnificus, a particularly virulent halophilic vibrio, has been isolated from the blood and skin necrotic lesion of a hemodialyzed patient with sepsis. The patient has had exposure of the skin to seawater. Various chronic conditions including renal failure have a great risk for developing septicemia due to V vulnificus.

It is necessary to inform persons with liver diseases or immunocompromising conditions of hazards associated with the consumption of undercooked seafood and seawater exposure.

HEMOCHROMATOSIS MUTATION  

Vibrio vulnificus Septicemia in a Patient With the Hemochromatosis HFE C282Y Mutation

Glenn S. Gerhard, MD, Kimberly A. Levin, MD, Jennifer Price Goldstein, MD, Margaret M. Wojnar, MD, Michael J. Chorney, PhD, and Deborah A. Belchis, MD

From the Departments of Pathology (Drs Gerhard, Levin, and Belchis), Internal Medicine (Drs Goldstein and Wojnar), and Microbiology and Immunology (Dr Chorney), Penn State College of Medicine, Hershey, Pa.

Arch Pathol Lab Med 2001;125:1107–1109. Abstract quote

Vibrio vulnificus is an extremely invasive gram-negative bacillus found in marine waters that causes overwhelming bacteremia and shock that is associated with high mortality. Impaired iron metabolism has been implicated in the susceptibility to V vulnificus bacterial infections.

We report a case of fatal V vulnificus sepsis in a 56-year-old man who died within 1 to 3 days after consuming raw seafood. At autopsy, he was found to have micronodular cirrhosis and iron overload. Postmortem genetic analysis revealed the presence of the hemochromatosis gene (HFE) C282Y mutation.

To our knowledge, this is this first documented fatal case of V vulnificus infection in a patient proven to carry the HFE C282Y mutation. Because this patient was heterozygous for the major hereditary hemochromatosis mutation and was not previously diagnosed with clinical iron overload, the spectrum of clinical susceptibilities to V vulnificus infection may include carriers of the C282Y mutation.

ORGAN TRANSPLANTATION  

Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis.

Ali A, Mehra MR, Stapleton DD, Kemmerly SA, Ramireddy K, Smart FW, Augustine S, Ventura HO.

Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, La 70121, USA.

J Heart Lung Transplant 1995 May-Jun;14(3):598-600 Abstract quote

We report two cases of Vibrio vulnificus wound infection leading to fulminant sepsis syndrome in immunocompromised solid organ transplant recipients. Features of clinical presentation in each of these cases suggest that host immune factors are of great importance in the virulence of this organism and that immunocompromised recipients of solid organ transplants are particularly vulnerable to life-threatening consequences from infection with Vibrio vulnificus.

Prompt institution of antibiotic therapy and early consideration for surgical wound debridement are the mainstay of successful management. Heart and other organ transplant recipients should be educated and warned about the hazards associated with raw oysters and shellfish consumption and asked to exercise caution when exposed to a salt water environment.

 

PATHOGENESIS CHARACTERIZATION
CAPSULE  

Differing resistance to polymorphonuclear cells of halophilic- and hypotonic-types of Vibrio vulnificus.

Tsuru S, Taniguchi M, Fujisawa H, Zinnaka Y, Nomoto K.

J Clin Lab Immunol 1987 Apr;22(4):185-9 Abstract quote

Bacterial growth and lethality of 4 strains of Vibrio vulnificus infection of mice were enhanced by gamma-irradiation but not by treatment with carrageenan. Therefore, protection against V. vulnificus, at least in the early phases, probably depends mainly on polymorphonuclear cells (PMN), since carrageenan depletes macrophages but not PMN. PMN dependent protection against infection differs for 2 types of V. vulnificus strains. Halophilic- and hypotonic-type were distinguished from the corresponding parent strain.

The hypotonic-type of the strains had capsular materials, as clarified by electron microscopic observation of the organisms stained with ruthenium red. On the other hand, halophilic-types either had no observable capsular materials, or incomplete materials, in contrast to the corresponding hypotonic-type. The corresponding halophilic- and hypotonic-types of the strains were compared for virulence in mice. The strains with capsular materials acquired resistance to phagocytic activity and were highly lethal.

Capsular materials of V. vulnificus are no doubt important for the expression of virulence.

 

LABORATORY/
RADIOLOGIC
CHARACTERIZATION
FLUOROGENIC  
Development of a simple and rapid fluorogenic procedure for identification of vibrionaceae family members.

Richards GP, Watson MA, Parveen S.

USDA, ARS, Delaware State University, 1200 N. DuPont Hwy., James W. W. Baker Center, Dover, DE 19901, USA.
Appl Environ Microbiol. 2005 Jul;71(7):3524-7. Abstract quote  

We describe a simple colony overlay procedure for peptidases (COPP) for the rapid fluorogenic detection and quantification of Vibrionaceae from seawater, shellfish, sewage, and clinical samples. The assay detects phosphoglucose isomerase with a lysyl aminopeptidase activity that is produced by Vibrionaceae family members.

Overnight cultures are overlaid for 10 min with membranes containing a synthetic substrate, and the membranes are examined for fluorescent foci under UV illumination. Fluorescent foci were produced by all the Vibrionaceae tested, including Vibrio spp., Aeromonas spp., and Plesiomonas spp. Fluorescence was not produced by non-Vibrionaceae pathogens. Vibrio cholerae strains O1, O139, O22, and O155 were strongly positive. Seawater and oysters were assayed, and 87 of 93 (93.5%) of the positive isolates were identified biochemically as Vibrionaceae, principally Vibrio vulnificus, Vibrio parahaemolyticus, Aeromonas hydrophila, Photobacterium damselae, and Shewanella putrefaciens. None of 50 nonfluorescent isolates were Vibrionaceae. No Vibrionaceae were detected in soil, and only A. hydrophila was detected in sewage.

The COPP technique may be particularly valuable in environmental and food-testing laboratories and for monitoring water quality in the aquaculture industry.
PCR  
Development of a quantitative real-time polymerase chain reaction targeted to the toxR for detection of Vibrio vulnificus.

Takahashi H, Hara-Kudo Y, Miyasaka J, Kumagai S, Konuma H.

Division of Microbiology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

J Microbiol Methods. 2005 Apr;61(1):77-85. Abstract quote  

The TaqMan assay, a quantitative real-time polymerase chain reaction (PCR), was developed to target the ToxR gene (toxR) of Vibrio vulnificus. The toxR of V. vulnificus was cloned and sequenced. Based on these results, we designed specific primers and a probe for use in the quantitative PCR assay.

Twenty-nine strains of V. vulnificus that were obtained from various sources produced a single PCR product. The amount of final amplification product and threshold cycle number were the same among the strains. We used the method to detect V. vulnificus in seawater and oyster samples.

We developed standard curves to quantitate V. vulnificus numbers using the PCR from seawater and oyster samples. The standard curves were not different from that of the pure culture of V. vulnificus. We found the assay was very sensitive detecting as few as 10 microbes per milliliter of seawater and oyster homogenate. Moreover, we evaluated the TaqMan assay to detect V. vulnificus in seawater samples. The numbers of V. vulnificus counted by the TaqMan assay were similar to those by a culture method in almost samples. The TaqMan assay was performed within 2 h compared to days using the culture method.

The results indicate the TaqMan assay method used in this study was rapid, effective and quantitative for monitoring V. vulnificus contamination in seawater and seafoods such as oysters.

Direct identification of Vibrio vulnificus in clinical specimens by nested PCR.

Lee SE, Kim SY, Kim SJ, Kim HS, Shin JH, Choi SH, Chung SS, Rhee JH.

Department of Microbiology, Chonnam National University Medical School, Chonnam National University, Kwangju 501-190, Republic of Korea.

J Clin Microbiol 1998 Oct;36(10):2887-92 Abstract quote

This study was performed to establish optimal nested PCR conditions and a high-yield DNA extraction method for the direct identification of Vibrio vulnificus in clinical specimens.

We designed two sets of primers targeting the V. vulnificus hemolysin/cytolysin gene. The target of the first primer set (P1-P2; sense, 5'-GAC-TAT-CGC-ATC-AAC-AAC-CG-3', and antisense, 5'-AGG-TAG-CGA-GTA-TTA-CTG-CC-3', respectively) is a 704-bp DNA fragment. The second set (P3-P4; sense, 5'-GCT-ATT-TCA-CCG-CCG-CTC-AC-3', and antisense, 5'-CCG-CAG-AGC-CGT-AAA-CCG-AA-3', respectively) amplifies an internal 222-bp DNA fragment. We developed a direct DNA extraction method that involved boiling the specimen pellet in a 1 mM EDTA-0.5% Triton X-100 solution. The new DNA extraction method was more sensitive and reproducible than other conventional methods. The DNA extraction method guaranteed sensitivity as well, even when V. vulnificus cells were mixed with other bacteria such as Escherichia coli or Staphylococcus aureus.

The nested PCR method could detect as little as 1 fg of chromosomal DNA and single CFU of V. vulnificus. We applied the nested PCR protocol to a total of 39 serum specimens and bulla aspirates from septicemic patients. Seventeen (94.4%) of the 18 V. vulnificus culture-positive specimens were positive by the nested PCR. Eight (42.1%) of the 19 culture-negative samples gave positive nested PCR results.

 

GROSS APPEARANCE/
CLINICAL VARIANTS
CHARACTERIZATION
General  

Clinical infections of Vibrio vulnificus: a case report and review of the literature.

Kumamoto KS, Vukich DJ.

Division of Emergency Medicine, University of Florida Health Science Center at Jacksonville, 32209-6511, USA.

J Emerg Med 1998 Jan-Feb;16(1):61-6 Abstract quote

Vibrio vulnificus is a marine Gram-negative bacillus that is recognized as a cause of fulminant primary septicemia and wound infections. One of the most common bacteria in seawater, V. vulnificus is concentrated in ocean filter feeders (e.g., oysters and clams). Primary septicemia can occur in patients, typically with underlying liver disease, who have acquired the organism through the gastrointestinal tract after recent consumption of raw shellfish.

Characterized by fevers, chills, and bullous skin lesions, V. vulnificus septicemia is associated with a mortality greater than 50%. With septic shock, mortality approaches 100%. Wound infections are seen after injury to the skin in a marine environment or from exposure of preexisting wounds to seawater.

Because of the high morbidity and mortality associated with V. vulnificus infections, effective treatment includes preventive measures to educate high-risk individuals, early search for and recognition of the disease, aggressive antibiotic therapy, supportive care, and, in the case of wound infections, aggressive debridement.

Review of this subject was prompted by a case of V. vulnificus primary septicemia and fulminant septic shock in a patient with the unusual presentation of pain in the lower extremities.

VARIANTS  
ENDOMETRITIS  

Vibrio vulnificus endometritis.

Tison DL, Kelly MT.

J Clin Microbiol 1984 Aug;20(2):185-6 Abstract quote

Vibrio vulnificus most frequently causes wound infections contracted after exposure to seawater or primary septicemias resulting from the consumption of raw oysters.

We report a case of endometritis caused by V. vulnificus. The infection was apparently acquired during the act of sexual intercourse in seawater in an area in which V. vulnificus has been frequently isolated.

The efficacy of treatment with an antimicrobial regimen which included tetracycline is discussed.

NECROTIZING FASCIITIS  

Necrotising fasciitis caused by Vibrio vulnificus.

Woo ML, Patrick WG, Simon MT, French GL.

J Clin Pathol 1984 Nov;37(11):1301-4 Abstract quote

A case of necrotising fasciitis caused by Vibrio vulnificus is described. The need for early recognition and aggressive surgical treatment are highlighted, and the necrotising infections due to V vulnificus described in the published work are reviewed.

OVARIES  
Tubo-ovarian abscess caused by Vibrio vulnificus.

Midturi J, Baker D, Winn R, Fader R.

Department of Medicine, Scott & White Memorial Hospital and Clinic, Scott, Sherwood and Brindley Foundation, The Texas A&M University System Health Science Center College of Medicine, Temple, TX 76508, USA.
Diagn Microbiol Infect Dis. 2005 Feb;51(2):131-3. Abstract quote  

Vibrio vulnificus is a Gram-negative bacterium that causes an aggressive infection with high mortality, especially in patients with liver disease.

Wound infections due to V. vulnificus occur via direct contamination of cutaneous tissues and can include the uterus.

We report a case of V. vulnificus tubo-ovarian infection from an unusual method of acquisition in the Gulf of Mexico.
PURPURA FULMINANS  
Vibrio vulnificus septicemia presenting as purpura fulminans.

Choi HJ, Lee DK, Lee MW, Choi JH, Moon KC, Koh JK.

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
J Dermatol. 2005 Jan;32(1):48-51. Abstract quote  

We present a case of Vibrio vulnificus septicemia presenting as purpura fulminans, which can often result in a catastrophic course.

This case had a fortunate outcome due to immediate and intensive empirical antibiotic treatment and the relatively healthy condition of the patient.

We focused on the prognostic factors for the relatively good outcome in this patient.
SEPTIC ARTHRITIS  

A fatal case of Vibrio vulnificus presenting as septic arthritis.

Johnson RW, Arnett FC.

Division of Rheumatology and Clinical Immunogenetics, University of Texas-Houston Medical School, 6431 Fannin, MSB 5.260, Houston, TX 77030, USA.

Arch Intern Med 2001 Nov 26;161(21):2616-8 Abstract quote

Vibrio vulnificus is an invasive gram-negative bacillus that may cause necrotizing cellulitis, bacteremia, and/or sepsis. Although V vulnificus infection is uncommon, it is frequently fatal and is usually attributed to ingestion of raw shellfish or traumatic exposure to a marine environment; patients are also often found to have a hepatic disorder (cirrhosis, alcohol abuse, or hemochromatosis) or an immunocompromised health status, and most commonly present with septicemia or a wound infection.

We describe a patient who presented with septic arthritis as the first clinical manifestation of a V vulnificus infection. The organism was subsequently identified in a synovial fluid aspirate.

WOUND INFECTION  
Wound infections caused by Vibrio vulnificus and other marine bacteria.

Oliver JD.

Department of Biology, University of North Carolina at Charlotte, 9201 University City Blvd, Charlotte, NC 28223, USA.
Epidemiol Infect. 2005 Jun;133(3):383-91. Abstract quote  

Infections caused by Vibrio vulnificus were first reported in 1979 by Blake et al. of the US Centers for Disease Control. At that time described as a 'rare, unnamed halophilic lactose-fermenting Vibrio species', V. vulnificus has emerged as the most virulent foodborne pathogen in the United States with a hospitalization rate of 0.910 and a case-fatality rate of 0.390. It is in addition a significant cause of potentially life-threatening wound infections.

Infections following ingestion of raw or undercooked seafood, commonly raw oysters, can lead to a primary septicaemia with a fatality rate of 50-60%. An unusual symptom, occurring in 69% of 274 cases reviewed by Oliver, is the development of secondary lesions, typically on the extremities, which are generally severe (often a necrotizing fasciitis) and require tissue debridement or amputation. These cases occur almost exclusively in males over the age of 50 years. Interestingly, this gender specificity has been found to be due to the female hormone oestrogen, which in some manner provides protection against the lethal V. vulnificus endotoxin. Further, most cases occur in persons with certain underlying diseases which are either immunocompromising or which lead to elevated serum iron levels (e.g. liver cirrhosis, chronic hepatitis, haemochromatosis). V. vulnificus infections resulting in primary septicaemia have been extensively studied, and the subject of several reviews.

This review concentrates on the wound infections caused by this marine bacterial pathogen, including the more recently described biotypes 2 and 3, with brief discussions of those caused by other marine vibrios, and the increasingly reported wound/skin infections caused by Mycobacterium marinum, Erysipelothrix rhusiopathiae, and Aeromnonas hydrophila.

Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group.

Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L, Soboh S, Colodner R, Cameron DN, Wykstra DL, Swerdlow DL, Farmer JJ

3rd. Infectious Diseases Unit, Ha'Emek Medical Center, Afula, Israel

Lancet 1999 Oct 23;354(9188):1421-4 Abstract quote

BACKGROUND: Vibrio vulnificus is a gram-negative bacterium that causes septicaemia and wound infection. Cases occur sporadically, and no previous outbreaks due to a common source or a clonal strain have been reported. In the summer and autumn of 1996 and 1997, an outbreak of invasive V. vulnificus infection occurred in Israel in people who had recently handled fresh, whole fish purchased from artificial fish-ponds.

METHODS: We reviewed clinical and epidemiological information, and undertook an environmental investigation to assess disease characteristics, modes of transmission, phenotypic characteristics of the bacterium, and fish-marketing policy. The clonal nature of 19 isolates was studied by biotyping, pulsed-field gel electrophoresis, and restriction-fragment length polymorphism (RFLP) analysis of a PCR fragment.

FINDINGS: During 1996-97, 62 cases of wound infection and bacteraemia occurred. 57 patients developed cellulitis, four had necrotising fasciitis, and one developed osteomyelitis. In all cases, the fish were cultivated in inland fish-ponds. In the summer of 1996, fish-pond managers initiated a new marketing policy, in which fish were sold alive instead of being packed in ice. Phenotypically, the isolates had five atypical biochemical test results. The isolates were non-typeable by pulsed-field gel electrophoresis, and all had the same PCR-RFLP pattern which had not been seen previously.

INTERPRETATION: The cause of the outbreak was a new strain of V. vulnificus, classified as biogroup 3. A new fish-marketing policy that began in 1996 may have exposed susceptible people to the organism.

Lower extremity manifestations of Vibrio vulnificus infection.

Laughlin TJ, Lavery LA.

University of Texas Health Science Center, Department of Orthopedics/Podiatry Section, San Antonio 78234, USA.

J Foot Ankle Surg 1995 Jul-Aug;34(4):354-7 Abstract quote

Vibrio vulnificus is a potentially lethal marine bacterium that has not been previously described in podiatric literature. A review of the microorganism's characteristics, susceptible patient population, and lower extremity manifestations of infection is presented. V. vulnificus is found as part of the normal flora of the Gulf of Mexico, Atlantic, and Pacific coastal waters and is often isolated from the filter feeding shellfish of these regions.

Its pathogenicity is generally reserved for the immunocompromised host, and is specifically related to disease states which exhibit high serum iron levels. V. vulnificus infections present in two distinct clinical syndromes: primary sepsis secondary to raw oyster ingestion, or localized infection from wound exposure to V. vulnificus-inhabited salt water. Both syndromes demonstrate characteristic skin lesions of the trunk and extremities that present as hemorrhagic bullae and progress to necrotic ulcerations.

Although V. vulnificus infection is rare, its extreme virulence in patients suffering from a chronic disease process and its manifestation of characteristic lower-extremity lesions require the podiatric physician to be able to recognize and treat such a condition.

 

HISTOPATHOLOGICAL VARIANTS CHARACTERIZATION
SKIN  

Out Hemorrhagic bullae associated with Vibrio vulnificus septicemia. Report of two cases.

Tyring SK, Lee PC.

Arch Dermatol 1986 Jul;122(7):818-20 Abstract quote

Bullous lesions associated with Vibrio vulnificus infection developed in two patients, both of whom had hepatic cirrhosis.

One patient had a recent history of ingestion of raw oysters, while the other patient had recently exposed skin lacerations to sea water. Both patients died within 24 hours of hospitalization, in spite of antibiotic treatment. Vibrio vulnificus was isolated from blood and bullae in both patients.

Histologic examination of skin biopsy specimens revealed epidermal/dermal separation and clusters of bacteria within dermal vessels with a negligible inflammatory response.

 

PROGNOSIS AND TREATMENT CHARACTERIZATION
PROGNOSIS  
LIVER DISEASE  
Chronic liver disease and consumption of raw oysters: a potentially lethal combination--a review of Vibrio vulnificus septicemia.

Haq SM, Dayal HH.

Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, TX, USA.

Am J Gastroenterol. 2005 May;100(5):1195-9. Abstract quote  

Vibrio vulnificus septicemia is the most common cause of fatality related to seafood consumption in the United States. It occurs predominantly in patients with chronic liver disease following consumption of raw oysters. V. vulnificus is a highly virulent human pathogen, normally found in warm estuarine and marine environment. It lodges in filter feeders like oysters. The onset of this illness is abrupt, rapidly progressing to septic shock with a high mortality. Clinicians managing patients with chronic liver disease need to educate their patients of the risk associated with the consumption of raw seafood, especially oysters.

A high index of suspicion is necessary for appropriate treatments, as doxycycline, the antibiotic of choice, is not usually a part of the empiric therapy for septicemia.

The high mortality associated with this septicemia demands aggressive preventive measures: susceptible individuals must be forewarned by signs displayed in restaurants; physicians must educate patients with chronic liver disease about the risk of raw oyster consumption; and harvesting methods which reduce contamination by V. vulnificus must be utilized.
TREATMENT  
ANTIBIOTICS  
In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.

Kim DM, Lym Y, Jang SJ, Han H, Kim YG, Chung CH, Hong SP.

Department of Laboratory Medicine, Chosun University Medical School, 588 Seoseok-dong, Dong-gu, Gwang-Ju 501-717, South Korea
Antimicrob Agents Chemother. 2005 Aug;49(8):3489-91. Abstract quote  

We performed time-kill studies of antimicrobial combinations that included minocycline, cefotaxime, and ciprofloxacin with Vibrio vulnificus ATCC 27562.

Cefotaxime-plus-ciprofloxacin combinations acted synergistically against V. vulnificus in vitro, and this combination regimen can be a good choice as the empirical treatment for suspected necrotizing fasciitis due to V. vulnificus.

Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline.

Bowdre JH, Hull JH, Cocchetto DM.

J Pharmacol Exp Ther 1983 Jun;225(3):595-8 Abstract quote

Seven antimicrobial agents, all effective against Vibrio vulnificus in vitro, were compared for in vivo efficacy in mice experimentally infected with V. vulnificus strain B3547. Mice were injected s.c. with 1 X 10(8) cells, and i.p. injection of antimicrobials was begun 1.5 hr later when mice were bacteremic and had edematous lesions at the injection site.

The study was done in two phases. Phase I was a dose-ranging experiment, using single injections within the range (on a body weight-adjusted basis) clinically useful in humans. Of 12 mice treated with tetracycline (4 mg/kg), 12 survived at 24 hr, compared to 0 of 21 saline-treated controls, 3 of 10 given ampicillin (32 mg/kg) and 2 of 3 given cefotaxime (20 mg/kg). There were no survivors at 24 hr in groups of 5 to 10 mice treated with cefazolin (32 mg/kg), carbenicillin (80 mg/kg), erythromycin (8 mg/kg) or gentamicin (8 mg/kg).

Phase II was designed to simulate clinical conditions using multiple dosing for 30 hr and scoring for survival at 96 hr. Of 12 mice given tetracycline (3 mg/kg every 12 hr), 12 survived, compared to 1 of 10 given cefotaxime (20 mg/kg every 6 hr), 0 of 12 given carbenicillin (40 mg/kg every 6 hr) and 0 of 12 given saline every 6 hr.

Tetracycline thus appears to be the agent of choice among those tested for in vivo efficacy against V. vulnificus in the mouse model.

Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment.

Chuang YC, Yuan CY, Liu CY, Lan CK, Huang AH.

Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China

Clin Infect Dis 1992 Aug;15(2):271-6 Abstract quote

From May 1985 through July 1990, 28 episodes of Vibrio vulnificus infection in 27 patients were encountered in five major hospitals in Taiwan.

The ages of patients ranged from 19 to 76 years; the ratio of male to female patients was 2:1. Eighteen episodes manifested as bacteremia and eight as wound infections alone. One patient each developed gastroenteritis and pneumonia after nearly drowning. Twenty-three patients exhibited skin manifestations. Twenty patients had underlying diseases. All patients were treated with antibiotics, and 14 also underwent some form of surgical treatment (incision and drainage, fasciotomy, debridement, or amputation). Thirteen of the 28 episodes were preceded by precipitating factors; most were due to ingestion of seafood or exposure of abraded skin to salt water. Ten of the 18 septicemic patients died--most within 48 hours of hospitalization. One patient without bacteremia who had a wound infection died.

Results of in vitro susceptibility studies suggested that ampicillin or a third-generation cephalosporin would be effective. Susceptibility to aminoglycosides was observed for greater than 90% of isolates.

We recommend combined therapy with a third-generation cephalosporin or ampicillin and an aminoglycoside along with appropriate surgical therapy for the treatment of V. vulnificus infection.

MODIFIED DAKIN'S SOLUTION  

Modified Dakin's solution for cutaneous vibrio infections.

Wilhelmi BJ, Calianos TA 2nd, Appelt EA, Ortiz ME, Heggers JP, Phillips LG.

Division of Plastic Surgery, The University of Texas Medical Branch, Galveston 77555-0724, USA.

Ann Plast Surg 1999 Oct;43(4):386-9 Abstract quote

Vibrio species, specifically Vibrio vulnificus, are known to be endemic to warm saltwater environments. As a human pathogen they are capable of causing severe, progressive, necrotizing infections. The lesions are bullous in nature and often require wide surgical debridement due to the aggressiveness of this organism. The literature supports prophylactic antibiotic therapy for those with preexisting hepatic dysfunction or immunocompromise.

The authors routinely implement prophylactic antibiotic coverage with doxycycline 100 mg every 12 hours for vibrio in patients with wounds exposed to or acquired in saltwater. In addition, they institute topical therapy with 0.025% sodium hypochlorite solution (modified Dakin's), based on their in vitro study of vibrio sensitivity to antimicrobials.

Over the past 2 years, the authors have treated 10 patients with this protocol for cutaneous vibrio infections confirmed by quantitative cultures. None of these patients experienced progression of infection requiring operative debridement-contrary to the aggressive nature of this organism documented in other reports.

SURGERY  

Primary skin infections secondary to Vibrio vulnificus: the role of operative intervention.

Halow KD, Harner RC, Fontenelle LJ.

Veterans Affairs Medical Center, Surgical Service, Biloxi, MS 39531, USA.

J Am Coll Surg 1996 Oct;183(4):329-34 Abstract quote

BACKGROUND: Vibrio vulnificus can cause rapidly spreading skin and soft tissue infections with significant associated morbidity and mortality. Patients with underlying chronic illness, such as cirrhosis, diabetes mellitus, or immunosuppression, have been noted to be at high risk for rapid progression of this infection. The importance of early antibiotic therapy has been reported but the role of operative intervention in these patients is less clear.

STUDY DESIGN: We report seven patients who were operatively treated from April 28, 1991 to September 22, 1995 for primary skin and soft tissue infections secondary to Vibrio vulnificus. We have also reviewed the recent literature. The impact of several variables including shock, increased white blood cell count, fever, and the timing of operative intervention on the length of hospital stay and intensive care unit stay was analyzed using the Spearman rank correlation. The impact of early compared with late operative intervention was analyzed using the Mann-Whitney U test. All patients had a history of underlying chronic illness and presented with skin infections in association with recent exposure to saltwater and to shellfish. No patient presented earlier than 24 hours from the time of initial infection. All patients underwent operative exploration within 46 hours of admission with thorough operative debridement of all necrotic tissue. Infection was confined to the skin and subcutaneous tissue.

RESULTS: There was no mortality among our patients. The presence of perioperative shock, fever, or elevated white blood cell count did not correlate with an increased intensive care unit stay or an increased hospital stay. Earlier operative exploration and debridement correlated with a decrease in the intensive care unit stay (p < 0.02, correlation coefficient = 0.991) and in the hospital stay (p < 0.02, correlation coefficient = 0.929). Patients who underwent debridement within 72 hours from the time of the infection had a significantly shorter intensive care unit stay (p = 0.0323) and total hospital stay (p = 0.0339).

CONCLUSIONS: We advocate operative exploration and thorough debridement of all necrotic tissue in high-risk patients with primary Vibrio vulnificus skin and soft tissue infections.

Henry JB. Clinical Diagnosis and Management by Laboratory Methods. Twentieth Edition. WB Saunders. 2001.
Rosai J. Ackerman's Surgical Pathology. Ninth Edition. Mosby 2004.
Sternberg S. Diagnostic Surgical Pathology. Fourth Edition. Lipincott Williams and Wilkins 2004.
Robbins Pathologic Basis of Disease. Seventh Edition. WB Saunders 2005.
DeMay RM. The Art and Science of Cytopathology. Volume 1 and 2. ASCP Press. 1996.
Weedon D. Weedon's Skin Pathology Second Edition. Churchill Livingstone. 2002
Fitzpatrick's Dermatology in General Medicine. 5th Edition. McGraw-Hill. 1999.
Weiss SW and Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. Fourth Edition. Mosby 2001.


Commonly Used Terms

Basic Principles of Disease
Learn the basic disease classifications of cancers, infections, and inflammation

Commonly Used Terms
This is a glossary of terms often found in a pathology report.

Diagnostic Process
Learn how a pathologist makes a diagnosis using a microscope

Surgical Pathology Report
Examine an actual biopsy report to understand what each section means

Special Stains
Understand the tools the pathologist utilizes to aid in the diagnosis

How Accurate is My Report?
Pathologists actively oversee every area of the laboratory to ensure your report is accurate

Got Path?
Recent teaching cases and lectures presented in conferences


Internet Links

Last Updated August 8, 2005

Send mail to The Doctor's Doctor with questions or comments about this web site.
Read the Medical Disclaimer.

Copyright © The Doctor's Doctor